
Articles

- Articles
University subsidiaries - are your arrangements compliant with charity law?
10 Oct 2025Subsidiaries are widely used in the higher education sector to open up the range of activities universities can undertake, diversify income streams, manage risk and access more agile operational and staffing models. While the legal and commercial reasons for structuring a new venture through a subsidiary may be varied, charity law compliance will often be a key driver. This article explores how charity law impacts decisions to use a subsidiary and the structuring of the relationship with the parent university.

- Articles
Transnational education (TNE): Keep Calm and Carry On
10 Oct 2025While the higher education (HE) sector has been abuzz with news of a new 'super-university', it may have paid less attention to the recent upticks in new overseas branch campuses and transnational education (TNE) students.

- Articles
Proposed reforms to residential conveyancing: what the Government is consulting on and what it could mean for you
09 Oct 2025On 6 October, the Government launched a consultation on reforming residential conveyancing in England and Wales. The proposals aim to make property transactions faster, more transparent and more reliable.

- Articles
Is it safe for your business to embrace AI?
08 Oct 2025Legal considerations and practical tips for businesses in the pharmaceuticals and life sciences sector.

- Articles
The MHRA launches the development of its new five-year strategy - can we predict their next steps?
08 Oct 2025The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it is developing a new strategy to provide its direction, mission, values and focus through to 2030. What should we expect?

- Articles
UK Life Sciences shows resilience and opportunity despite concerns over recent big pharma announcements
08 Oct 2025It's been a challenging few weeks for the UK life sciences sector. Following the breakdown of the talks with the Government to provide a more competitive reimbursement scheme for pharma, there have been a number of high-profile decisions that have created big concerns for the future of the sector. However, there have been some good news stories too, including a resilient message from MedCity - the life sciences arm of London and Partners, with whom VWV is a partner.





